2025-04-10
Development of a novel adenovirus type 4 vector as a promising respiratory vaccine vehicle
2025-04-10 • Jinghan Xu, Busen Wang, Zhenghao Zhao, Shipo Wu, Zhe Zhang, Shilin Liu, Nan Huo, Wanru Zheng, Yi Chen, Zhiqiang Gao, Z. Jiao, Tianyu Liu, Li Zhu, L...
Introduction Adenovirus (Ad) vectors are widely used for gene delivery, and some of them have been approved for vaccine development. In particular, the recombinant COVID-19 vaccine for inhalation, which was developed using adenovirus type 5 (Ad5), represents a milestone in respiratory immunization. Owing to the high pre-existing immunity (PEI) to Ad5, the development of an adenoviral vector with lower PEI and higher immunogenicity has been explored. However, the majority of the developed novel Ad vectors showed su…